← Back
Data updated: Jul 17, 2026
E5 PHARMA
Generics Pharmaceuticals
E5 PHARMA is a generic drug manufacturer with 2 FDA-approved products.
2019
Since
2
Drugs
-
Trials
0
New Drugs (2yr)
E5 PHARMA's Key Drugs
E5 PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
E5 PHARMA's Recent FDA Approvals
New NDA/BLA approvals for E5 PHARMA over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
E5 PHARMA's Therapeutic Areas
Disease areas where E5 PHARMA has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
E5 PHARMA Pipeline Snapshot
Active clinical trials for E5 PHARMA across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2019-12-20
- Latest
- 2026-03-09
- Applications
- 2
FDA Sponsor Names
E5 PHARMAE5 PHARMA INC